Cell line with endogenous EGFR(vIII) expression is a suitable model for research and drug development purposes

Glioblastoma is the most common and malignant brain tumor, characterized by high cellular heterogeneity. About 50% of glioblastomas are positive for EGFR amplification, half of which express accompanying EGFR mutation, encoding truncated and constitutively active receptor termed EGFR(vIII). Currentl...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Stec, Wojciech J., Rosiak, Kamila, Siejka, Paulina, Peciak, Joanna, Popeda, Marta, Banaszczyk, Mateusz, Pawlowska, Roza, Treda, Cezary, Hulas-Bigoszewska, Krystyna, Piaskowski, Sylwester, Stoczynska-Fidelus, Ewelina, Rieske, Piotr
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2016
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5077985/
https://ncbi.nlm.nih.gov/pubmed/27004406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8201
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料